One of the great benefits of receiving cancer care at an academic health center is that our clinician-scientists participate in cutting-edge research. In addition to multi-institutional clinical trial groups, the Radiation Oncology Department is involved in in-house protocols (sets of instructions for treatment, or treatment plans) that are used at the University of Florida. Some involve only the Radiation Oncology Department; many others represent joint effort by two or more departments. Most of these protocols are considered “standard of care”, but some are investigational.
UF Radiation Oncology has over 70 Outcome and Clinical Trials Open
- Every patient treated in Gainesville is able to participate in the RADTRAC outcomes tracking protocol. RADTRAC includes over 55,000 treatments dating to the 1960s.
- Over 98% of all UFHPTI patients are approved to the Outcomes Tracking Protocol.
Selected Clinical Trials:
- P53 mutational status and circulating-free HPV DNA for the management of HPV-associated Oropharyngeal Squamous Cell Cancers
- De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal Squamous Cell Carcinoma
- Phase II Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients with Head and Neck Cancer
- Early Markers of Subclinical Pulmonary Vascular Radiation Toxicity in Breast Cancer
- A Randomized Trial of Music to Decrease Anxiety in Women Starting Radiation Therapy for Cancer
- RADCOMP: Pragmatic Phase III Randomized Trial of Proton Vs. Photon Therapy for Patients with Non-Metastatic Breast Cancer Receiving Comprehensive Nodal Radiation: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial
- Imaging the Patterns of Breast Cancer Early Metastases